Remedy Informatics Welcomes Dr. Scott Howard as New Chief Medical Officer - KHGI-TV/KWNB-TV/KHGI-CD-Grand Island, Kearney, Hastings

Remedy Informatics Welcomes Dr. Scott Howard as New Chief Medical Officer

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Remedy Informatics

Former Medical Information Officer at St. Jude Children's Research Hospital, selected for his innovative and patient-centric approach to oncology research and treatment, to help shape future of Remedy's informatics solutions

SALT LAKE CITY, May 29, 2014 /PRNewswire/ -- Remedy Informatics, the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced today that Scott C. Howard, MD, MSc, will join the company's executive team as Chief Medical Officer (CMO).

Dr. Scott C. Howard, Remedy Informatics' new Chief Medical Officer, and former Professor and Medical Information Officer at St. Jude Children's Research Hospital.

Dr. Howard comes to Remedy from St. Jude Children's Research Hospital where he was a professor and Director of Clinical Trials for St. Jude's International Outreach Program. St. Jude Children's Research Hospital is an internationally recognized leader in research and treatment for children with cancer.

At St. Jude, Dr. Howard directed the development of the online, multilingual Pediatric Oncology Network Database (www.POND4Kids.org) that facilitates outcome assessment and cancer care improvement in more than 200 centers in 60 countries worldwide. Since 1998, Dr. Howard has worked with pediatric oncology professionals in 87 nations to improve outcomes for children with cancer in low- and middle-income countries. He served as St. Jude's Medical Information Officer from 2009 to 2011 to oversee several key informatics projects, including: the transition to an all-electronic medical record; the implementation of computerized provider order entry (CPOE) for all medications, including complex chemotherapy regimens; and the development and deployment of an electronic chemotherapy roadmap for children with cancer. Throughout his time at St. Jude, Dr. Howard consistently demonstrated his passion to convert patient information into tools that drive improvements in healthcare.

"As the demand for our products continues to fuel explosive growth, it is important that we have the right people in place to maintain this trajectory," said Gary Kennedy, Founder and CEO of Remedy Informatics. "Over the course of his career Scott has demonstrated a keen understanding of the role of technology innovations in accelerating discoveries and developing new and more effective treatments in healthcare, and he will be a key asset for us moving forward. We are excited to add Scott to our executive team as we work to tangibly, measurably and permanently transform life sciences research and healthcare delivery around the world."

Dr. Howard is board certified in Internal Medicine, Pediatrics, and Hematology/Oncology and is a member of numerous societies, including the International Society of Pediatric Oncology (SIOP), the American Society of Hematology and the American Society of Pediatric Hematology/Oncology.

Also on the oncology front, Remedy Informatics was recently selected by the American Society of Clinical Oncology (ASCO) to provide the new technology platform for its Quality Oncology Practice Initiative (QOPI®). ASCO's goal is to implement a more flexible system that will allow its staff to update the system and conduct routine changes as needed. With the new Remedy-engineered registry system in place, participating practices will be able to report data from a variety of sources, including direct entry and EHRs, into the QOPI system and receive feedback on the program's quality measures and their progress in improving cancer care.

For information about Remedy's industry-leading registry-based clinical intelligence solutions, or to request a demonstration, please visit our website, www.remedyinformatics.com.

About Remedy Informatics

Founded in 2003, Remedy Informatics is a leading provider of registry-based oncology, cardiovascular and other informatics software products for life sciences research and healthcare delivery. The company, whose mission is to tangibly, measurably and permanently transform life sciences research and healthcare delivery around the world, serves a wide range of leading life sciences, translational research and healthcare institutions globally, including the Cleveland Clinic, Massachusetts General Hospital, Baylor Health Care System and many more. Built on the innovative Mosaic™ Platform, all of Remedy's products are fully configurable and user-friendly. For more information visit: www.remedyinformatics.com.

Media Contacts

Kristofer Beldin, Remedy Informatics, (801) 733-3335 (office)/(801) 870-9407 (cell), kris.beldin@remedyinformatics.com

Remedy Informatics is a leading provider of registry-based oncology, cardiovascular and other informatics software products for life sciences research and healthcare delivery. The company, whose mission is to tangibly, measurably and permanently improve life sciences research and healthcare delivery around the world, serves a wide range of leading life sciences, translational research and healthcare institutions globally, including the Cleveland Clinic, Massachusetts General Hospital, Baylor Health Care System and many more...

Photo - http://photos.prnewswire.com/prnh/20140529/92061
Logo - http://photos.prnewswire.com/prnh/20130213/SF59513LOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General and news information or questions:
Across the Midlands Information:
events@nebraska.tv
Comments: comments@nebraska.tv
News:
news@nebraska.tv
Phone: 308-743-2494
News Fax: 308-743-2660
All content © Copyright 2000 - 2014 WorldNow and NTV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.